Shares of Morepen Laboratories fell sharply over 5% in early trade on May 27 after the company reported subdued fourth-quarter earnings, weighed down by a sharp decline in operating profit and margin contraction.
As of 9:36 AM, Morepen Laboratories shares were trading near the day’s low after opening at Rs 42.80 on the NSE. The stock touched an intraday low of Rs 41.38 and a high of Rs 42.80 during the session. The stock had settled at Rs 43.92 in the previous session.
Live trading volume stood at 24,75,398 shares.
For the quarter ended March 2026, the company reported consolidated revenue of Rs 485 crore, up 4.0% year-on-year from Rs 466 crore in the corresponding quarter last year.
However, EBITDA declined 42.2% to Rs 24.4 crore compared to Rs 42.2 crore a year ago. EBITDA margin also narrowed significantly to 5.0% from 9.1% in the year-ago period.
Net profit for the quarter fell 22.7% year-on-year to Rs 15.7 crore against Rs 20.3 crore reported in the same quarter last fiscal.
The weak operational performance and sharp margin compression weighed on investor sentiment, leading to selling pressure in the stock during early morning trade.
On a broader basis, the stock remains below its 52-week high of Rs 70.50, while the 52-week low stands at Rs 33.05.
Disclaimer: This article is for informational purposes only and should not be considered as investment advice. Stock market investments are subject to market risks. Readers should consult certified financial advisors before making any investment decisions. The views and data discussed are based on publicly available information and company disclosures. Past performance does not guarantee future returns. Neither the author nor the publisher is responsible for any losses arising from investment decisions based on this article.